Experiment 694281
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | HOCHSTER,H: ORATZ,R: ETTINGER,DS: BORDEN,E:. (1999). A PHASE II STUDY OF DIDEMNIN B (NSC 325319) IN ADVANCED MALIGNANT MELANOMA: AN EASTERN COOPERATIVE ONCOLOGY GROUP STUDY (PB687).. 16(3) |
| Amount utilized | |
| Compound isolated | |
| Disease | AT A STARTING DOSE OF 4.2 MG/G; DOES WERE ESCALATED TO 4.9 AND 5.6 MG/G IN CYCLES 2 AND 3; NINETEEN PATIENTS, INCLUDING 7 PATIENTS WITH ANAPHYLACTOID REACTIONS IN THE FIRST OR SECOND CYCLE; 7 PATIENTS WITH STABLE DISEASE AFTER 3 CYCLES. |
| Dose amount | VAR |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |